Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

NCT00120172 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped positive results from a larger study with same regimen was released.

Conditions

Colorectal Cancer
Neoplasm Metastasis

Interventions

DRUG: oxaliplatin, capecitabine, bevacizumab

Sponsor

Geriatric Oncology Consortium

Collaborators

[object Object]